Cyclooxygenase-2 Inhibitors in Inflammation and Cancer (Q169000): Difference between revisions

Latest revision as of 21:22, 21 September 2024

Research on medications that block COX-2 enzyme to reduce inflammation and cancer risk.

Language	Label	Description	Also known as
English	Cyclooxygenase-2 Inhibitors in Inflammation and Cancer	Research on medications that block COX-2 enzyme to reduce inflammation and cancer risk.

0 references

0 references

@@ aliases / en / 0 / aliases / en / 0 @@
-Cyclooxygenase-2 Inhibitors
@@ aliases / en / 1 / aliases / en / 1 @@
-Inflammation
@@ aliases / en / 2 / aliases / en / 2 @@
-Cancer
@@ aliases / en / 3 / aliases / en / 3 @@
-Prostaglandins
@@ aliases / en / 4 / aliases / en / 4 @@
-NSAIDs
@@ aliases / en / 5 / aliases / en / 5 @@
-Cardiovascular Risk
@@ aliases / en / 6 / aliases / en / 6 @@
-Colorectal Cancer
@@ aliases / en / 7 / aliases / en / 7 @@
-Chemoprevention
@@ aliases / en / 8 / aliases / en / 8 @@
-Prostaglandin E2
@@ aliases / en / 9 / aliases / en / 9 @@
-COX-2
@@ description / en / description / en @@
-This cluster of papers focuses on the use of cyclooxygenase-2 (COX-2) inhibitors, such as rofecoxib, celecoxib, and naproxen, in the context of inflammation and cancer
+Research on medications that block COX-2 enzyme to reduce inflammation and cancer risk.
@@ Property / same as @@
-https://openalex.org/T10678
@@ Property / same as: https://openalex.org/T10678 / rank @@
-Normal rank
@@ Property / OpenAlex ID @@
+T10678
@@ Property / OpenAlex ID: T10678 / rank @@
+Normal rank